Evidence map›Paper›PMID 32466176›Full record

ReviewNanomaterials (Basel, Switzerland)2020

Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design.

Ximena Zottig, Mélanie Côté-Cyr, Dominic Arpin, Denis Archambault, Steve Bourgault

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Nucleation and Growth of Amyloid Fibrils.The journal of physical chemistry. B · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ximena ZottigDepartment of Chemistry, Université du Québec à Montréal, Montreal, H2L 2C4, Canada.
Mélanie Côté-CyrDepartment of Chemistry, Université du Québec à Montréal, Montreal, H2L 2C4, Canada.
Dominic ArpinDepartment of Chemistry, Université du Québec à Montréal, Montreal, H2L 2C4, Canada.
Denis ArchambaultThe Swine and Poultry Infectious Diseases Research Centre, CRIPA, Saint-Hyacinthe, J2S 2M2, Canada.
Steve BourgaultDepartment of Chemistry, Université du Québec à Montréal, Montreal, H2L 2C4, Canada.

Funding

International Development Research Centre 108517Natural Sciences and Engineering Research Council of Canada RGPIN-2018-06209
6 · The paper itself

Abstract

Life-inspired protein supramolecular assemblies have recently attracted considerable attention for the development of next-generation vaccines to fight against infectious diseases, as well as autoimmune diseases and cancer. Protein self-assembly enables atomic scale precision over the final architecture, with a remarkable diversity of structures and functionalities. Self-assembling protein nanovaccines are associated with numerous advantages, including biocompatibility, stability, molecular specificity and multivalency. Owing to their nanoscale size, proteinaceous nature, symmetrical organization and repetitive antigen display, protein assemblies closely mimic most invading pathogens, serving as danger signals for the immune system. Elucidating how the structural and physicochemical properties of the assemblies modulate the potency and the polarization of the immune responses is critical for bottom-up design of vaccines. In this context, this review briefly covers the fundamentals of supramolecular interactions involved in protein self-assembly and presents the strategies to design and functionalize these assemblies. Examples of advanced nanovaccines are presented, and properties of protein supramolecular structures enabling modulation of the immune responses are discussed. Combining the understanding of the self-assembly process at the molecular level with knowledge regarding the activation of the innate and adaptive immune responses will support the design of safe and effective nanovaccines.

Indexed as

adjuvantimmune responsenanoassembliesnanovaccineproteinself-assemblysupramolecular structurevaccine

Identifiers

PMID32466176
PMCPMC7281494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.